Page 4 - Procaps Group News Today

Key Insights Insiders appear to have a vested interest in Procaps Group's growth, as seen by their sizeable ownership...

Procaps Ranked First Among Companies in the Pharmaceutical Segment in Colombia for the 5th Consecutive Year Procaps Group (NASDAQ:PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical

Procaps Group S.A. (NASDAQ:PROC – Get Free Report) saw a large decline in short interest during the month of October. As of October 15th, there was short interest totalling 26,700 shares, a decline of 20.8% from the September 30th total of 33,700 shares. Currently, 0.1% of the shares of the company are sold short. Based […]

Experienced Pharma Professional Brings Wealth of International Industry and Governance Experience to Board ...

Procaps Group , a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that it will participate at the CPHI Barcelona 2023, that will take place from October 24th to...

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Oct 2, 2023--

Procaps Group, a leading integrated LATAM healthcare and pharmaceutical services company specialised in providing contract development and manufacturing services for advanced Softgel technologies for the Healthcare and Nutrition

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Sep 15, 2023--

Procaps Group has signed an agreement with BDR for 27 oncology molecules for Latin America, including 20 Tirosyne Kinase Inhibitors (TKIs).

The Agreement Substantially Increases Procaps Participation in the Oncology Market in the LatAm Region ...